Clinical Trial Update: A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

View source ↗

Summary

This document provides a clinical trial update for Pfizer's CIBINQO (abrocitinib) in people with atopic dermatitis, noting the study is currently ACTIVE_NOT_REC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING